SEC Form D · filed February 18, 2021
Silence Therapeutics plc
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Michael H. Davidson · London, United KingdomDirectorBarbara Ruskin · London, United KingdomExecIain Ross · San Francisco, CADirectorCraig Tooman · London, United KingdomExecMark Rothera · London, United KingdomExec · DirectorRomano Steven · London, United KingdomDirectorGiles Campion · Leiden, P7ExecMark Rothera · London, United KingdomExec · DirectorDave Lemus · London, United KingdomDirectorIain Ross · San Francisco, CADirectorMichael H. Davidson · London, United KingdomDirectorAlistair Gray · London, United KingdomDirectorDave Lemus · London, United KingdomDirectorRomano Steven · London, United KingdomDirectorBarbara Ruskin · London, United KingdomExecAlistair Gray · London, United KingdomDirectorCraig Tooman · Kansas City, KSExecJames Ede-Golightly · London, United KingdomDirectorGiles Campion · Leiden, P7ExecJames Ede-Golightly · London, United KingdomDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗